Growth hormone deficiency in the transition period: Body composition and gonad function

Journal of Endocrinological Investigation

Volumn 34, Issue 9, 2011, Pages 709-715

  Balercia, G ^a   Giovannini, L ^a   Paggi, F ^a   Spaziani, M ^b   Tahani, N ^b   Boscaro, M ^a   Lenzi, A ^b   Radicioni, A ^b  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Body composition; GH deficiency; Gonads; Transition

Indexed keywords

GONADORELIN; GROWTH HORMONE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; RECOMBINANT GROWTH HORMONE; SOMATOSTATIN;

ADENOHYPOPHYSIS; ADRENARCHE; ARTHRALGIA; AUTOSOMAL DOMINANT DISORDER; AUTOSOMAL RECESSIVE DISORDER; BODY COMPOSITION; BODY MASS; BONE DENSITY; BONE METABOLISM; CANCER RECURRENCE; CARPAL TUNNEL SYNDROME; CELL MATURATION; CRANIOPHARYNGIOMA; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; EMPTY SELLA SYNDROME; GAMETOGENESIS; GENE MUTATION; GERM CELL TUMOR; GONAD FUNCTION; GROWTH HORMONE DEFICIENCY; GROWTH RATE; HEADACHE; HISTIOCYTOSIS X; HORMONE SUBSTITUTION; HUMAN; HYPERINSULINISM; HYPOPHYSIS GONAD SYSTEM; HYPOPHYSITIS; HYPOTHALAMUS; IMPAIRED GLUCOSE TOLERANCE; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; LOW DRUG DOSE; MALE FERTILITY; MYALGIA; NEOPLASM; NONHUMAN; OLIGOSPERMIA; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PERIPHERAL EDEMA; QUALITY OF LIFE; REPRODUCTION; SEXUAL DEVELOPMENT; SHORT SURVEY; SPERMATOZOON COUNT; SPERMATOZOON MOTILITY; STEROIDOGENESIS; TRAUMATIC BRAIN INJURY; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

BODY COMPOSITION; BONE DENSITY; ENERGY METABOLISM; GONADS; GROWTH DISORDERS; GROWTH HORMONE; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS; RECOMBINANT PROTEINS;

EID: 84856148372     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/7804     Document Type: Short Survey

References (71)

1. Molitch ME. Growth hormone treatment in adults with growth hormone deficiency: the transition. J Endocrinol Invest 2011, 34: 150-4.
2. Giustina A, Mazziotti G, Canalis E. Growth hormone, insulin-like growth factors, and the skeleton. Endocr Rev 2008, 29: 535-59.
3. Salomon F, Cuneo RC, Hesp R, et al. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 1989, 321: 1797-803. (Pubitemid 20015573)
4. Clayton PE, Cuneo RC, Juul A, Monson JP, Shalet SM, Tauber M; European Society of Paediatric Endocrinology. Consensus statement on the management of the GH-treated adolescent in the transition to adult care. Eur J Endocrinol 2005, 152: 165-70. (Pubitemid 40309560)
5. Aimaretti G, Ambrosio MR, Di Somma C, et al. Hypopituitarism induced by traumatic brain injury in the transition phase. J Endocrinol Invest 2005, 28: 984-9. (Pubitemid 43265763)
6. Nguyen VT, Misra M. Transitioning of children with GH deficiency to adult dosing: changes in body composition. Pituitary 2009, 12: 125-35.
7. Attanasio AF, Shavrikova E, Blum WF, et al Hypopituitary Developmental Outcome Study Group. Continued growth hormone (GH) treatment after final height is necessary to complete somatic development in childhood-onset GH-deficient patients. J Clin Endocrinol Metab 2004, 89: 4857-62. (Pubitemid 39403060)
8. Hulthén L, Bengtsson BA, Sunnerhagen KS, Hallberg L, Grimby G, Johannsson G. GH is needed for the maturation of muscle mass and strength in adolescents. J Clin Endocrinol Metab 2001, 86: 4765-70. (Pubitemid 33026072)
9. Hoffman AR, Kuntze JE, Baptista J, et al. Growth hormone (GH) replacement therapy in adult-onset GH deficiency: effects on body composition in men and women in a double-blind, randomized, placebo-controlled trial. J Clin Endocrinol Metab 2004, 89: 2048-56. (Pubitemid 38619832)
10. Maghnie M, Aimaretti G, Bellone S, et al. Diagnosis of GH deficiency in the transition period: accuracy of insulin tolerance test and insulin-like growth factor-I measurement. Eur J Endocrinol 2005, 152: 589-96. (Pubitemid 40575804)
11. Ghigo E, Aimaretti G, Arvat E, Camanni F. Growth hormone-releasing hormone combined with arginine or growth hormone secretagogues for the diagnosis of growth hormone deficiency in adults. Endocrine 2001, 15: 29-38.
12. Gasco V, Corneli G, Beccuti G, et al. Retesting the childhood-onset GH-deficient patient. Eur J Endocrinol; 2008, 159: S45-52.
13. Veldhuis JD, Roemmich JN, Richmond EJ, et al. Endocrine control of body composition in infancy, childhood, and puberty. Endocr Rev 2005, 26: 114-46. (Pubitemid 40209389)
14. Johannsson G, Albertsson-Wikland K, Bengtsson BA. Discontinuation of growth hormone (GH) treatment: metabolic effects in GH-deficient and GH-sufficient adolescent patients compared with control subjects. Swedish Study Group for Growth Hormone Treatment in Children. J Clin Endocrinol Metab 1999, 84: 4516-24.
15. Vahl N, Juul A, Jorgensen JO, Orskov H, Skakkebaek NE, Christiansen JS. Continuation of growth hormone (GH) replacement in GH-deficient patients during transition from childhood to adulthood: a two-year placebo-controlled study. J Clin Endocrinol Metab 2000, 85: 1874-81. (Pubitemid 32269292)
16. O'Halloran DJ, Tsatsoulis A, Whitehouse RW, Holmes SJ, Adams JE, Shalet SM. Increased bone density after recombinant human growth hormone (GH) therapy in adults with isolated GH deficiency. J Clin Endocrinol Metab 1993, 76: 1344-8. (Pubitemid 23155462)
17. Sartorio A, Ortolani S, Conti A, Cherubini R, Galbiati E, Faglia G. Effects of recombinant growth hormone (GH) treatment on bone mineral density and body composition in adults with childhood onset growth hormone deficiency. J Endocrinol Invest 1996, 19: 524-9. (Pubitemid 26372265)
18. Vandeweghe M, Taelman P, Kaufman JM. Short and long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone-deficient males. J Clin Endocrinol Metab 1993, 39: 409-15. (Pubitemid 23308417)
19. Conway GS, Szarras-Czapnik M, Racz K, et al; 1369 GHD to GHDA Transition Study Group. Treatment for 24 months with recombinant human GH has a beneficial effect on bone mineral density in young adults with childhood-onset GH deficiency. Eur J Endocrinol 2009, 160: 899-907.
20. Drake WM, Carroll PV, Maher KT, et al. The effect of cessation of growth hormone (GH) therapy on bone mineral accretion in GH-deficient adolescents at the completion of linear growth. J Clin Endocrinol Metab 2003, 88: 1658-63. (Pubitemid 36623384)
21. Shalet SM, Shavrikova E, Cromer M, et al. Effect of growth hormone (GH) treatment on bone in postpubertal GH-deficient patients: a 2-year randomized, controlled, dose-ranging study. J Clin Endocrinol Metab 2003, 88: 4124-9. (Pubitemid 37158031)
22. Biller B, Sesmilo G, Baum H, Hayden D, Schoenfeld D, Klibanski A. Withdrawal of long-term physiological growth hormone (GH) administration: differential effects on bone density and body composition in men with adult-onset GH deficiency. J Clin Endocrinol Metab 2000, 85: 970-6. (Pubitemid 32269335)
23. Underwood LE, Attie KM, Baptista J; Genentech Collaborative Study Group. Growth hormone (GH) dose-response in young adults with childhood-onset GH deficiency: a two-year, multicenter, multiple-dose, placebo-controlled study. J Clin Endocrinol Metab 2003, 88: 5273-80. (Pubitemid 37452727)
24. Andreassen TT, Oxlund H. The effects of growth hormone on cortical and cancellous bone. J Musculoskelet Neuronal Interact 2001, 2: 49-58.
25. Canalis E. Insulin-like growth factors and osteoporosis. Bone 1997, 21: 215-6. (Pubitemid 27404078)
26. Rosén T, Wilhelmsen L, Landin-Wilhelmsen K, Lappas G, Bengtsson BA. Increased fracture frequency in adult patients with hypopituitarism and GH deficiency. Eur J Endocrinol 1997, 137: 240-5. (Pubitemid 27405107)
27. Hogler W, Shaw N. Childhood growth hormone deficiency, bone density, structures and fractures: scrutinizing the evidence. Clin Endocrinol (Oxf) 2010, 72: 281-9.
28. Hilczer M, Smyczynska J, Stawerska R, Lewinski A. Effects of one-year low-dose growth hormone (GH) therapy on body composition, lipid profile and carbohydrate metabolism in young adults with childhood-onset severe GH deficiency confirmed after completion of growth promotion. Endokrynol Pol 2008, 59: 292-300.
29. Bell J, Parker KL, Swinford RD, Hoffman AR, Maneatis T, Lippe B. Long-term safety of recombinant human growth hormone in children. J Clin Endocrinol Metab 2010, 95: 167-77.
30. Sartorio A, Molinari E, Riva G, Conti A, Morabito F, Faglia G. Growth hormone treatment in adults with childhood onset growth hormone deficiency: effects on psychological capabilities. Horm Res 1995, 44: 6-11.
31. Colao A, Di Somma C, Salerno M, Spinelli L, Orio F, Lombardi G. The cardiovascular risk of GH-deficient adolescents. J Clin Endocrinol Metab 2002, 87: 3650-5. (Pubitemid 34879507)
32. Carroll PV, Drake WM, Maher KT, et al. Comparison of continuation or cessation of growth hormone (GH) therapy on body composition and metabolic status in adolescents with severe GH deficiency at completion of linear growth. J Clin Endocrinol Metab 2004, 89: 3890-5. (Pubitemid 39071490)
33. Götherström G, Bengtsson BA, Bosaeus I, Johannsson G, Svensson J. A 10-year, prospective study of the metabolic effects of growth hormone replacement in adults. J Clin Endocrinol Metab 2007, 92: 1442-5. (Pubitemid 46562361)
34. Florakis D, Hung V, Kaltsas G, et al. Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study. Clin Endocrinol (Oxf) 2000, 53: 453-9.
35. Shimonovitz S, Zacut D, Ben Chetrit A, Ron M. Growth hormone status in patients with maturation arrest of spermatogenesis. Hum Reprod 1993, 8: 919-21. (Pubitemid 23193689)
36. Gravance CG, Breier BH, Vickers MH, Casey PJ. Impaired sperm characteristics in postpubertal growth-hormone-deficient dwarf (dw/dw) rats. Anim Reprod Sci 1997, 49: 71-6. (Pubitemid 28042799)
37. Radicioni A, Paris E, Dondero F, Bonifacio V, Isidori A. Recombinant-growth hormone (rec-hGH) therapy in infertile men with idiopathic oligozoospermia. Acta Eur Fertil 1994, 25: 311-7.
38. Kanzaki M, Morris PL. Growth hormone regulates steroidogenic acute regulatory protein expression and steroidogenesis in Leydig cell progenitors. Endocrinology 1999, 140: 1681-6. (Pubitemid 29149237)
39. Carani C, Mantovani R, Procopio M, Del Rio G, Rossetto R, Granata AR. GH/IGF-I axis in azoospermia in primary and secondary hypogonadism: a study before and during replacement therapy. Int J Androl 1999, 22: 184-9. (Pubitemid 29253599)
40. Bartke A, Chandrashekar V, Bailey B, Zaczek D, Turyn D. Consequences of growth hormone (GH) overexpression and GH resistance. Neuropeptides 2002, 36: 201-8.
41. Nakae J, Kido Y, Accili D. Distinct and overlapping functions of insulin and IGF-I receptors. Endocr Rev 2001, 22: 818-35. (Pubitemid 34214297)
42. Zhou J, Xu BC, Maheshwari HG, et al. A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc Natl Acad Sci 1997, 94: 13215-20. (Pubitemid 27518502)
43. Schneider HJ, Pagotto U, Stalla GK. Central effects of the somatotropic system. Eur J Endocrinol 2003, 149: 377-92. (Pubitemid 37461517)
44. Codner E, Cassorla F. Growth hormone and reproductive function. Mol Cell Endocrinol 2002, 186: 133-6. (Pubitemid 34233703)
45. Chandrashekar V, Bartke A, Coschigano KT, Kopchick JJ. Pituitary and testicular function in growth hormone receptor gene knockout mice. Endocrinology 1999, 140: 1082-8. (Pubitemid 29104206)
46. Lackey BR, Gray SL, Henricks DM. The insulin-like growth factor (IGF) system and gonadotropin regulation: actions and interactions. Cytokine Growth Factor Rev 1999, 10: 201-17. (Pubitemid 30041400)
47. Hiney JK, Srivastava V, Nyberg CL, Ojeda SR, Dees WL. Insulin like growth factor I of peripheral origin acts centrally to accelerate the initiation of female puberty. Endocrinology 1996, 137: 3717-28. (Pubitemid 26284638)
48. Jia XC, Kalmijn J, Hsueh AJ. Growth hormone enhances follicle stimulating hormone-induced differentiation of cultured rat granulosa cells. Endocrinology 1986, 118: 1401-9. (Pubitemid 16078513)
49. Chuzel F, Clark AM, Avallet O, Saez JM. Transcriptional regulation of the lutropin/human choriogonadotropin receptor and three enzymes of steroidogenesis by growth factors in cultured pig Leydig cells. Eur J Biochem 1996, 239: 8-16. (Pubitemid 26228134)
50. Mazerbourg S, Bondy CA, Zhou J, Monget P. The insulin-like growth factor system: a key determinant role in the growth and selection of ovarian follicles? A comparative species study. Reprod Dornest Anim 2003, 38: 247-58. (Pubitemid 37053846)
51. Monget P, Fabre S, Mulsant P, et al. Regulation of ovarian folliculogenesis by IGF and BMP system in domestic animals. Dornest Anim Endocrinol 2002, 23: 139-54.
52. Spiliotis BE. Growth hormone insufficiency and its impact on ovarian function. Ann N Y Acad Sci 2003, 997: 77-84. (Pubitemid 38491061)
53. Leschek EW, Troendle JF, Yanovski JA, et al. Effect of growth hormone treatment on testicular function, puberty, and adrenarche in boys with non-growth hormone-deficient short stature: A randomized, double-blind, placebo-controlled trial. J Pediatr 2001, 138: 406-10. (Pubitemid 32207146)
54. Ankarberg-Lindgren C, Norjavaara E, Wikland KA. Short boys treated with growth hormone show normal progression of testicular size and achieve normal serum testosterone concentrations. Eur J Endocrinol 2002, 146: 681-5. (Pubitemid 34552502)
55. Hokken-Koelega A, Van Pareren Y, Arends N, Boonstra V. Efficacy and safety of long-term continuous growth hormone treatment of children born small for gestational age. Horm Res 2004, 62 (Suppl 3): 149-54.
56. Radicioni AF, Paris E, De Marco E, Anzuini A, Gandini L, Lenzi A. Testicular function in boys previously treated with recombinant-human growth hormone for non-growth hormone-deficient short stature. J Endocrinol Invest 2007, 30: 931-6. (Pubitemid 351350828)
57. Bertelloni S, Baroncelli GI, Viacava P, Massimetti M, Simi P, Saggese G. Can growth hormone treatment in boys without growth hormone deficiency impair testicular function? J Pediatr 1999, 135: 367-70. (Pubitemid 30180513)
58. Balducci R, Toscano V, Mangiantini A, Bianchi P, Guglielmi R, Boscherini B. The effect of growth hormone administration on testicular response during gonadotropin therapy in subjects with combined gonadotropin and growth hormone deficiencies. Acta Endocrinol (Copenh) 1993, 128: 19-23. (Pubitemid 23055236)
59. Chatelain PG, Sanchez P, Saez JM. Growth hormone and insulin-like growth factor-1 treatment increase testicular luteinizing hormone receptors and steroidogenic responsiveness of growth hormone deficient dwarf mice. Endocrinology 1991, 128: 1857-62.
60. Carani C, Granata A, De Rosa M, et al. The effect of chronic treatment with GH on gonadal function in men with isolated GH deficiency. Eur J Endocrinol 1999, 140: 224-30. (Pubitemid 29155580)
61. Jørgensen JO, Pedersen SA, Thuesen L, et al. Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet 1989, 1: 1221-5. (Pubitemid 19140325)
62. Rutherford OM, Jones DA, Round JM, Buchanan CR, Preece MA. Changes in skeletal muscle and body composition after discontinuation of growth hormone treatment in growth hormone deficient young adults. Clin Endocrinol (Oxf) 1991, 34: 469-75.
63. Colle M, Auzerie J. Discontinuation of growth hormone therapy in growth-hormone-deficient patients: assessment of body fat mass using bioelectrical impedance. Horm Res 1993, 39: 192-6. (Pubitemid 23344792)
64. De Boer H, Van Der Veen EA. Why retest young adults with childhood-onset growth hormone deficiency? J Clin Endocrinol Metab 1997, 82: 2032-6. (Pubitemid 27287557)
65. Savage MO, Drake WM, Carroll PV, Monson JP. Transitional care of GH deficiency: when to stop GH therapy. Eur J Endocrinol 2004, 151: S61-5. (Pubitemid 39276349)
66. Lanes R, Soros A, Flores K, Gunczler P, Carrillo E, Bandel J. Endothelial function, carotid artery intima-media thickness, epicardial adipose tissue, and left ventricular mass and function in growth hormone-deficient adolescents: apparent effects of growth hormone treatment on these parameters. J Clin Endocrinol Metab 2005, 90: 3978-82. (Pubitemid 41058160)
67. Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Shalet SM, Vance ML; Endocrine Society's Clinical Guidelines Subcommittee, Stephens PA. Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2006, 91: 1621-34.
68. Wolthers T, Hoffman DM, Nugent AG, Duncan MW, Umpleby M, Ho KK. Oral estrogen antagonizes the metabolic actions of growth hormone in growth hormone-deficient women. Am J Physiol Endocrinol Metab 2001, 281: E1191-6. (Pubitemid 34001193)
69. Attanasio AF, Lamberts SW, Matranga AM, et al. Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. Adult Growth Hormone Deficiency Study Group. J Clin Endocrinol Metab 1997, 82: 82-8. (Pubitemid 27021275)
70. Radovick S, DiVall S. Approach to the growth hormone-deficient child during transition to adulthood. J Clin Endocrinol Metab 2007, 92: 1195-200. (Pubitemid 46556384)
71. Saggese G, Baroncelli Gl, Vanacore T, Fiore L, Ruggieri S, Federico G. Indications and strategies for continuing GH treatment during transition from late adolescence to early adulthood in patients with GH deficiency: The impact on bone mass. J. Endocrinol Invest 2004, 27: 596-602. (Pubitemid 39268762)